Selective Protection by Anguidine of Normal versus Transformed Cells against 1-ß-D-Arabinofuranosylcytosine and Adriamycin

Robert A Hromas, Barthel Barlogie, Douglas Swartzendruber, Benjamin Drewinko

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Anguidine, a protein synthesis inhibitor, has been shown previously to induce a reversible arrest of cell progression through all phases of the mitotic cycle without inducing appreciable cell kill. This “frozen” cell cycle state provided protection of Chinese hamster ovary cells against the lethal effects of 1-ß-D-arabinofuranosylcytosine, Adriamycin, hydroxyurea, 5-fluorouracil, and hyperthermia. We now report on the preferential induction of cytostasis by anguidine in normal WI-38 fibroblasts, occurring at one-tenth of the dosage required to inhibit the cycle progression of WI-38 VA13 cells, the SV40 transformant. Pretreatment with anguidine at a concentration producing effective inhibition of normal cell cycle traverse while permitting sustained proliferation of transformed cells resulted in almost complete protection of WI-38 normal cells against the growth-inhibitory effects of 1-ß-D-arabinofuranosylcytosine and Adriamycin, without reducing the antiproliferative effects of these two agents against WI-38 VA13 transformed cells. Thus, this cytokinetic concept of preferential normal tissue protection should be explored in vivo to increase the therapeutic index of cancer chemotherapy.

Original languageEnglish (US)
Pages (from-to)1135-1137
Number of pages3
JournalCancer Research
Volume43
Issue number3
StatePublished - Mar 1 1983
Externally publishedYes

Fingerprint

diacetoxyscirpenol
Cytarabine
Doxorubicin
Cell Cycle
Protein Synthesis Inhibitors
Hydroxyurea
Cricetulus
Fluorouracil
Ovary
Fever
Fibroblasts
Cell Proliferation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Selective Protection by Anguidine of Normal versus Transformed Cells against 1-ß-D-Arabinofuranosylcytosine and Adriamycin. / Hromas, Robert A; Barlogie, Barthel; Swartzendruber, Douglas; Drewinko, Benjamin.

In: Cancer Research, Vol. 43, No. 3, 01.03.1983, p. 1135-1137.

Research output: Contribution to journalArticle

Hromas, Robert A ; Barlogie, Barthel ; Swartzendruber, Douglas ; Drewinko, Benjamin. / Selective Protection by Anguidine of Normal versus Transformed Cells against 1-ß-D-Arabinofuranosylcytosine and Adriamycin. In: Cancer Research. 1983 ; Vol. 43, No. 3. pp. 1135-1137.
@article{7a0cb6b2fec7477591c111406c37eb46,
title = "Selective Protection by Anguidine of Normal versus Transformed Cells against 1-{\ss}-D-Arabinofuranosylcytosine and Adriamycin",
abstract = "Anguidine, a protein synthesis inhibitor, has been shown previously to induce a reversible arrest of cell progression through all phases of the mitotic cycle without inducing appreciable cell kill. This “frozen” cell cycle state provided protection of Chinese hamster ovary cells against the lethal effects of 1-{\ss}-D-arabinofuranosylcytosine, Adriamycin, hydroxyurea, 5-fluorouracil, and hyperthermia. We now report on the preferential induction of cytostasis by anguidine in normal WI-38 fibroblasts, occurring at one-tenth of the dosage required to inhibit the cycle progression of WI-38 VA13 cells, the SV40 transformant. Pretreatment with anguidine at a concentration producing effective inhibition of normal cell cycle traverse while permitting sustained proliferation of transformed cells resulted in almost complete protection of WI-38 normal cells against the growth-inhibitory effects of 1-{\ss}-D-arabinofuranosylcytosine and Adriamycin, without reducing the antiproliferative effects of these two agents against WI-38 VA13 transformed cells. Thus, this cytokinetic concept of preferential normal tissue protection should be explored in vivo to increase the therapeutic index of cancer chemotherapy.",
author = "Hromas, {Robert A} and Barthel Barlogie and Douglas Swartzendruber and Benjamin Drewinko",
year = "1983",
month = "3",
day = "1",
language = "English (US)",
volume = "43",
pages = "1135--1137",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Selective Protection by Anguidine of Normal versus Transformed Cells against 1-ß-D-Arabinofuranosylcytosine and Adriamycin

AU - Hromas, Robert A

AU - Barlogie, Barthel

AU - Swartzendruber, Douglas

AU - Drewinko, Benjamin

PY - 1983/3/1

Y1 - 1983/3/1

N2 - Anguidine, a protein synthesis inhibitor, has been shown previously to induce a reversible arrest of cell progression through all phases of the mitotic cycle without inducing appreciable cell kill. This “frozen” cell cycle state provided protection of Chinese hamster ovary cells against the lethal effects of 1-ß-D-arabinofuranosylcytosine, Adriamycin, hydroxyurea, 5-fluorouracil, and hyperthermia. We now report on the preferential induction of cytostasis by anguidine in normal WI-38 fibroblasts, occurring at one-tenth of the dosage required to inhibit the cycle progression of WI-38 VA13 cells, the SV40 transformant. Pretreatment with anguidine at a concentration producing effective inhibition of normal cell cycle traverse while permitting sustained proliferation of transformed cells resulted in almost complete protection of WI-38 normal cells against the growth-inhibitory effects of 1-ß-D-arabinofuranosylcytosine and Adriamycin, without reducing the antiproliferative effects of these two agents against WI-38 VA13 transformed cells. Thus, this cytokinetic concept of preferential normal tissue protection should be explored in vivo to increase the therapeutic index of cancer chemotherapy.

AB - Anguidine, a protein synthesis inhibitor, has been shown previously to induce a reversible arrest of cell progression through all phases of the mitotic cycle without inducing appreciable cell kill. This “frozen” cell cycle state provided protection of Chinese hamster ovary cells against the lethal effects of 1-ß-D-arabinofuranosylcytosine, Adriamycin, hydroxyurea, 5-fluorouracil, and hyperthermia. We now report on the preferential induction of cytostasis by anguidine in normal WI-38 fibroblasts, occurring at one-tenth of the dosage required to inhibit the cycle progression of WI-38 VA13 cells, the SV40 transformant. Pretreatment with anguidine at a concentration producing effective inhibition of normal cell cycle traverse while permitting sustained proliferation of transformed cells resulted in almost complete protection of WI-38 normal cells against the growth-inhibitory effects of 1-ß-D-arabinofuranosylcytosine and Adriamycin, without reducing the antiproliferative effects of these two agents against WI-38 VA13 transformed cells. Thus, this cytokinetic concept of preferential normal tissue protection should be explored in vivo to increase the therapeutic index of cancer chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0020697980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020697980&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1135

EP - 1137

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -